← Back to Clinical Trials
Recruiting NCT06344910

PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC

Trial Parameters

Condition Heart Failure With Reduced Ejection Fraction
Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study Type OBSERVATIONAL
Phase N/A
Enrollment 900
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-05-21
Completion 2025-05
Interventions
Best practice alert for the notification of patients with HFrEF and recommended evidence-based therapies

Brief Summary

This is a prospective cohort study, where the investigators aim to investigate the effect of implementation of an electronic nudge alerting clinicians to the prescription of the 4 key pharmacological classes for the treatment of patients with heart failure and reduced ejection fraction (HFrEF) at the outpatient clinic in the Netherlands.

Eligibility Criteria

Inclusion Criteria: * Age \> 18 years * Treatment for HFrEF at the outpatient clinic cardiology. * Documented reduced ejection fraction of \<40% based on cardiac ultrasound or cardiac magnetic resonance imaging. Exclusion Criteria: * Opt-out for the use of routine clinical data for research purposes

Related Trials